British firm GSK and French multinational Sanofi announced the collaboration in the hope of providing long-lasting immunity to Covid-19 cheaply and on a mass scale.
@ Independent
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.